Download PDFPDF

Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

  • Published on:
    Gaviscon Infant® is effective symptomatically in infant reflux-associated symptoms

    Dear Editor

    In response to the comments of Paisal (1), regarding our study on the influence of Gaviscon Infant® on gastro-oesophageal reflux in infants studied by the new physiologically appropriate modality of combined intraluminal oesophageal pH/impedance (2), we would like to make the following points.

    Commenting on the study design he points to two studies which found benefit of Gaviscon. What he...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Gaviscon on gastro-oesophageal reflux in infants: A poorly effective treatment?
    • Francesco Cresi, Paediatric Specialist
    • Other Contributors:
      • Francesco Savino, Cristina Marinaccio, Leandra Silvestro

    Dear Editor,

    We read with interest the recent article by Del Buono et al. evaluating the effect of sodium and magnesium alginate (Gaviscon) on gastro-oesophageal reflux (GER) in infants [1]. It provides an objective assessment of the effects of a drug widely used in the treatment of paediatric GER by means of a double-blind drug vs placebo trial, in which the effects of each treatment were evaluated by means of...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Absence of wash-out period between Gaviscon and placebo may be responsible for anomalous findings

    Dear Editor,

    Oesophageal pH monitoring has been used to monitor gastro-oesophageal reflux (GOR). However, Buono et al. point out that this method will not record instances of 'neutral-reflux' after a feed (1). They say that multiple intraluminal impedance measurement is a more appropriate way to assess GOR. Using the technique they have found that Gaviscon does not reduce reflux. The number and height of reflux with Gav...

    Show More
    Conflict of Interest:
    None declared.